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ABSTRACT 
AIM: To assess whether acupuncture is an effective alternative to pharmacological 
management in the prophylaxis of migraine 
RATIONALE: Epidemiological studies suggest that migraine has a huge impact on the world 
population in terms of pain, side-effects and cost of loss productivity at work. 
METHODS: internet based research of relevant and recent randomized controlled trials and 
subsequent comparative analysis. 
RESULTS: Six relevant and recent papers were found to be published on migraine 
prophylaxis incorporating acupuncture treatment and drug control interventions. All reviewed 
papers varied considerably in study design and quality, making comparative analysis 
challenging. Nevertheless, a meta-analysis from the available quantitative data was performed 
and provided results that are concordant with the cumulative effect of acupuncture treatment. 
Furthermore, statistically significant increases in the percentage of responders and decreases 
in rescue medication suggested that acupuncture is an effective prophylaxis for migraines 
without the adverse events of standard pharmacological management. 
CONCLUSION: There is evidence to suggest that acupuncture could be considered as a first 
line treatment for chronic migraine, particularly in patients who cannot tolerate standardized 
drug therapy. NICE guidelines may need to be updated. Forthcoming trials need to be 
redesigned to optimize the full potential of acupuncture in the treatment of migraines.  
 
1. INTRODUCTION 
Conditions that have been linked to migraines were described in detail dating back to 3000BC 
from Babylonian writings. Papyrus scrolls from around 1550BC buried alongside a mummy 
in Thebes describe very similar symptoms to what we now regard as a migraine. 
Hippocrates in 460 BC described a shining light that was typically seen in one eye followed 
by severe pain that started on one side of the head and enveloped the whole head and down 
the neck. 
Hua T 'o was a Chinese surgeon in the 2nd century who was given credit for the invention of 
anaesthetic drugs, he was also one of the first to take acupuncture needles to cure migraines. 
According to Traditional Chinese Medicine: migraines belong to the categories of "Tou Feng" 
(wind in the head) and "Pian Tou Tong" (pain of the half head) and were either caused by 
external pathogens or internal excess or deficiency, many of which related to the seven 
emotions and effecting the Liver. 
A headache is a pain of any kind in or around the head. There are several types. 
Common visual disturbances during migraine attacks include flashing or coloured lights. 
Nausea and/or vomiting may occur during an attack. Common prerequisites for a migraine 
include emotional strain, anxiety or around menstruation. Certain foods, like chocolate, may 
trigger off migraines and they usually occur between puberty and middle-life. 
Attacks differ from person to person, but typically start with visual symptoms. In severe 
cases, pins and needles may occur or a weakness may arise on one part or sides of the body. 
These pre-symptoms can last for half an hour, then the pain will start on one side of the head. 
It will be severe and throbbing. Photophobia may also occur, plus pallor and sweating 
(Gascoigne, 2001).  
Western pharmacological medication may come at a price concerning side effects from long 
and short term use. Pathologies include nausea, stomach upset, stomach ulcers, irregular or 
fast heart rate and seizures (Gascoigne, 2001). For the above reasons, this project needs to 
answer whether acupuncture can be deemed a safe alternative to prophylactic drugs. 
Drug treatment for migraines is divided into two broad categories: acute (sudden onset) and 
prophylactic (to reduce frequency and intensity of recurrent attacks). For the purpose of this 
research project only prophylactic will be discussed. It is worth mentioning briefly about the 
drugs that are used 
for prophylactic. Drugs used are divided into six broad categories.  
Acupuncture is part of an ancient system of Chinese medicine developed over 2000 years ago. 
Its core principle is the view of no separation between mind and body and that imbalances in 
one will generally lead to imbalances in the other (Birch et al., 2008). The primary concern of 
Western medicine is to isolate disease categories or agents of disease where identification of 
symptoms and causes are the main goal. Chinese medicine, however, considers all 
physiological and psychological presenting symptoms as well as external environmental 
factors so forming an overall pattern of disharmony from which a diagnosis and treatment 
plan can be devised (Kaptchuk et al., 2000). 
Acupuncture has gained popularity in the Western hemisphere since the late seventies 
(Kaptchuk et al., 2000), and as a result of this growth and with the development of evidence-
based medicine, there has been increasing demand for acupuncture and Chinese medicine in 
general to be able to demonstrate its efficacy and effectiveness through the use of rigorous 
clinical trials in the form of randomised controlled experiments. 
Acupuncture is considered a relatively safe therapy with few side effects (BMA 2004), 
whereas drug therapy has many possible side effects, especially when the patient takes them 
on a long-term basis. 
Successful treatment of headaches and migraines relies on the expertise of the acupuncturist 
to identify and treat the both Ben and Biao, the affected Zangfu and associated channels. 
The primary purpose of this research project was to assess whether acupuncture is an effective 
alternative to drug therapy as a prophylactic treatment for migraine headaches.  
Acupuncture in the West is still not fully accepted, with much doubt, fear and unawareness 
from the public (MacPherson et al., 2008), because of this, further research is still needed to 
prove the efficacy and effectiveness of acupuncture as a safe alternative to drug therapy as a 
prophylactic treatment for migraine headache. 
The reason as to why this question needs to be investigated is the fact that epidemiological 
studies report that migraine headaches have adverse effects on the human population in terms 
of pain, resources and costs, both personal and to the world national health systems. 
2.  METHODS 
2.1  Identification and selection of studies to be reviewed 
A broad search strategy was used in order to identify as many articles as possible. The 
following databases and sources were searched: PubMed, The Cochrane Central Register of 
Controlled Trials, The Journal of Chinese Medicine Archive, Allied and Complementary 
Medicine (AMED), Acubriefs, Acupuncture Research Resource Centre (ARRC). 
The search terms used for the electronic databases were: acupuncture, migraine, prophylaxis, 
prophylactic migraine drugs, flunarizine, metoprolol.  
In addition to systematic searches at the beginning of the research project, regular checks 
were carried out in PubMed in order to identify new studies by searching for migraine and 
acupuncture. Facco’s study was identified in one of these regular checks.  
2.2  Criteria for considering studies for this review 
Randomized controlled trials were selected for this review, which is to say, controlled trials in 
which allocation to treatment groups (acupuncture and drug control) was randomized. Study 
participants had to be diagnosed with suffering from migraine for over one year. The 
acupuncture treatment involved needle insertion and the control intervention had to be 
prophylactic drug treatment, excluding acute treatment interventions.  
Studies had to be less than 10 years old and had to be original research papers. In addition 
they had to provide results on outcome measures in which statistical analysis had been 
performed.  
2.3  Data collection and analysis 
Abstracts identified during the selection process were read and screened in order to identify 
candidate studies for inclusion. Full texts of shortlisted papers were obtained and screened in 
order to carry out the final selection. 
Relevant general information was extracted from selected studies using an information 
extraction form. Information extracted included country, number of recruitment centres, 
blindness, treatment groups, inclusion of sham acupuncture, number of patients randomized, 
number of patients treated, number of patients analyzed, number of patients per treatment 
group, presence of aura, type of acupuncture treatment (standardized, individualized or semi-
standardized), duration of acupuncture treatment, number of acupuncture sessions per week, 
total number of acupuncture sessions, acupuncturist training and expertise, drug treatment 
used, drug type, duration of prophylactic drug treatment, type of rescue medication allowed 
and whether usage was measured, use of headache diaries by patients, duration of baseline 
period, duration of follow-up period and measurement time points (in weeks and months). 
Before quantitative data was extracted, as explained below, outcome measures studied were 
annotated in the information extraction form, including: proportion of responders, frequency 
of migraine attacks, migraine days, pain intensity, rescue medication, adverse events, physical 
and/or mental health questionnaires.  
The precise time-points in which studies evaluated their chosen outcome measurements varied 
considerably. In order to allow for comparative analysis, time-points were grouped as follows: 
early time-points around 1-2 months after baseline (T1), mid time-points around 3 months 
after baseline (T2) and around 1 year after baseline (T3). 
3.  RESULTS 
3.1  Comparative description of studies 
Six randomised controlled trials that compared the efficacy of acupuncture prophylactic 
treatment to standard drug controlled interventions were reviewed. They were published 
between 2002 and 2013. 
A total of 1,552 migraine patients participated in the reviewed studies. The mean number of 
patients in each trial was 259, with a median of 114. The smallest trial included 70 patients 
and the largest 990. Two trials originated from Germany, two from Italy, one from China and 
one from Taiwan.  
All trials used parallel-group designs. Five trials had two groups (one acupuncture group and 
a control group) and one trial had three groups (verum acupuncture, sham acupuncture and 
standard drug treatment). A two-group trial followed a double-dummy design where the 
acupuncture group was also administered a placebo treatment and the control intervention 
included sham acupuncture and drug treatment; this design was the only design that allowed 
patients to be completely blinded to the type of treatment they were receiving. Therefore, two 
trials (Diener and Wang) used sham acupuncture in their control interventions.  
Most trials included patients diagnosed as having migraine with or without aura. One trial 
(Allais et al., 2002) was restricted to women with migraine without aura.  
Acupuncture treatments were semi-standardized in four trials. They included both “basic” 
points and additional individualized points based on traditional Chinese syndrome diagnosis. 
Two trials used completely standardized acupuncture treatments. 
The length of acupuncture treatment varied to a great extent ranging between 4 weeks and 24 
weeks (from 1 month to nearly 6 months) with a median acupuncture treatment of 17 weeks 
(4 months). The total number of acupuncture sessions was also quite variable among studies, 
ranging from 10 to 32 sessions, with a median of 16 acupuncture sessions.  
The length of control drug treatment also varied widely among studies, ranging from 4 weeks 
to 24 weeks (1 month to nearly 6 months), with a median of 12 weeks. Two studies compared 
acupuncture treatment with flunarizine (a calcium-channel blocker), two studies used anti-
convulsants (valproic acid and topiramate) as standard prophylactic drug treatment, one study 
used a beta-blocker drug (metoprolol) and one study used a combination of beta-blockers, 
flunarizine and valproic acid.  
Rescue medication for acute attacks was allowed in all studies. Frequency of rescue 
medication use was evaluated in all trials as an outcome measurement.  
All studies used a headache diary kept by patients for measuring primary outcomes. Trials 
included a pre-treatment baseline period prior to randomization into the parallel treatment 
groups. Four out of six trials followed patients for 6 months or more after randomization. 
The complex headache data on number of migraine days, frequency, percentage of 
responders, pain intensity and use of rescue medication were measured and presented in 
highly variable ways, making systematic extraction and comparison difficult.  
Systematic analysis was further complicated by variable follow-up time-points, including 4, 6, 
8, 12, 13, 24 and 26 weeks after randomization (Table 4). For comparative purposes time-
points were grouped as early (4-8 weeks, 1-2 months), mid (12-13 weeks, 3 months) and late 
(24-26 weeks, 6 months) time-points.  
3.2  Quantitative analysis of outcome measurements 
Outcome measurement quantitative data was extracted from the six reviewed studies and 
represented to allow comparative analysis.  
The number of responders was measured in four of the six studies reviewed: Diener, Streng, 
Wang and Yang. All four studies reported an increase in the 
amount of responders (3 months after baseline) in the group treated with acupuncture 
compared with control interventions. Two studies, Wang and Yang, found these differences to 
be statistically significant (p=0.042 and p<0.01, respectively).  
Comparative data for the percentage of responders showed that the greatest difference 
between acupuncture and control groups was found in Yang’s study. Yang’s included the 
highest number of total acupuncture sessions (24). This was followed by Wang’s, whose 
study provided 12 acupuncture sessions per patient, and also presented the second highest 
difference between acupuncture and control groups. Conversely, it was observed that Diener 
showed the smallest difference in the percentage of responders  
between acupuncture and control groups and was also the study with the least total number of 
acupuncture sessions provided.  
A possible correlation between the percentage of responders and the length of treatment was 
therefore analyzed for this review. Interestingly, the percentage of responders at 3 months 
showed a very strong correlation (R
2
=0.935) with the total number of acupuncture sessions 
received. This data provides evidence that supports the widely held notion that the effects of 
acupuncture treatment are cumulative and therefore its effects related to the number of 
acupuncture sessions received. No evidence of correlation was found between the percentage 
of responders and the length of drug treatment (R
2
=0.001, data not shown). 
Two of the six studies reviewed were designed with a control intervention that included sham 
acupuncture: Diener (sham control group) and Wang (double-dummy approach). Both studies 
investigated the percentage of responders and the number of migraine days per month as 
outcome measurements. 
Statistically significant differences in the percentage of responders between acupuncture and 
control groups were found both in Diener’s and Wang’s studies. Differences in Diener’s study 
were confined to the first time-point analyzed at around 2 months (T1), with differences not 
reaching significant values at time-points two and three (T2 and T3). No statistically 
significant differences between the verum and sham acupuncture groups were reported. 
Wang’s study showed statistically significant differences in the percentage of responders 
between the acupuncture and control group (that included sham acupuncture) at both time-
points studied (T1 and T2, p=0.043 and p=0.042, respectively). 
When the total number of migraine days was investigated, Diener only reported a significant 
difference between verum and sham groups at the third and last time-point analyzed (6 
months). On the other hand, the reduction in the number of migraine days per month was 
highly statistically significant in Wang’s study at both time-points analyzed (p<0.01).  
Rescue medication for acute migraine attacks was used as an outcome measurement in all six 
studies reviewed; however, different variables were studied, including: number of analgesic 
doses taken per month, number of days per month when rescue medication has been used, 
number of participants taking rescue medication and percentage of participants taking rescue 
medication.  
In order to obtain data that allows inter-study comparisons for this review, data related to the 
number/percentage of participants taking rescue medication was extracted from three studies 
(Diener, Wang and Yang) and converted into percentages of participants for comparisons. 
Two out of the three studies analyzed (Wang and Yang) revealed statistically significant 
Linear regression analysis was used to investigate a possible correlation between the 
percentage of participants taking rescue medication and the total number of acupuncture 
sessions received. This correlation was found to be moderately strong (R
2
=0.5455), again 
providing evidence that supports the cumulative nature of acupuncture treatment.  
Five of the six clinical trials reviewed, all but Diener’s, provided data in regards to adverse 
events reported by participants as a result of treatment received. All five studies reported 
significantly higher numbers of adverse events in participants that were taking prophylactic 
drugs. These ranged from 10% to 66%, with an average of 44% participants on drugs 
reporting adverse events compared to an average of 8% of participants receiving acupuncture 
complaining of adverse events (0-15%). 
4. DISCUSSION 
A limitation of this project was the fact that only six relevant and recent papers had been 
published on migraine prophylaxis and therefore available for review. In addition, all six 
reviewed trials analysed a variety of different outcome measurements, such as pain intensity, 
responder rates, migraine days and rescue medication, at differing time points ranging from 4 
to 26 weeks and sometimes using different quantitative variables. Furthermore, treatment 
courses also differed both for acupuncture and drugs in regards to length, number of 
acupuncture sessions or drug dose.  
Their varying designs posed limitations for the systematic analysis and evaluation of their 
results, making comparisons of the six papers challenging. To improve these limitations, 
designs of future trials should be more homogeneous, designed in a similar fashion, so as to 
facilitate future comparative studies that can generate rigorous data to inform clinical practice.  
This project provided a comparative study, both quantitatively and qualitatively, of the 
reviewed papers. A particular strength of this project was its meta-analysis of the available 
literature in a small scale. This project generated a new data set from the quantitative data 
extracted from the reviewed papers which allowed the study of the relationship between the 
number of acupuncture sessions and outcome measurements such as the percentages of 
responders and the rescue medication use. Results presented in this review showed evidence 
of strong correlations between the number of total acupuncture sessions administered and the 
increase in the percentage of responders, and also with the reduction of rescue medication use. 
Importantly, these results provide new evidence that supports the traditionally held view that 
acupuncture is cumulative and its effects increase with the number of treatments received.   
In the two German trials (Diener et al., 2006) (Streng 2006) a large proportion of patients 
withdrew informed consent immediately after being allocated to the control (drug) group. 
Further along these trials additional patients also withdrew. This suggests that some patients 
that signed for the trial did so with the expectation or hope of being assigned to the 
acupuncture group, and withdrew if this was not the case. This may be a source of bias. 
Interestingly, verum acupuncture did not prove to be superior to sham acupuncture in the 
reviewed study that used a sham control intervention. This observation is concordant with 
previous reports (Deng et al., 2007). 
There may be three possible explanations: a) acupuncture may act as a potent placebo, b) 
sham acupuncture may produce direct neuro-physiological changes that may relieve several 
migraine symptoms and c) due to a lack of blinding, comparisons with routine care and 
prophylactic drug treatment may be biased (MacPherson et al., 2008). 
The average effect of placebo interventions seems to be small (Chan et al., 2004); however, 
evidence exists that more complex placebos create larger effects (Kaptchuk et al., 2000). 
Evidence also exists that sham acupuncture has a greater effect than a placebo pill. Available 
evidence suggest important mechanism for placebo to work include expectations, 
conditioning, reduction in anxiety and social support (Benedetti, 2008). Acupuncture 
treatment involves repeated sessions, hands on treatment, empathy, and often, a very personal 
case history and an individualized diagnosis and treatment plan. 
Sham acupuncture protocols involve needling in non-specific TCM points, but with the same 
frequency and the length as verum acupuncture (Diener et al., 2006) (Wang et al., 2011). 
Some researchers suggest that most neuro-physiological mechanisms involve in acupuncture 
do not have to have point specificity (Bäcker et al., 2004). Furthermore, the quality of 
acupuncture treatment in clinical trials is often disputed. Trials analysed for this review used 
standardized or semi-standardized needling protocols, which greatly differ from highly 
individualized routine care. Routine care may also include additional modalities such as Tui 
Na, cupping and electrotherapy. The challenges lie in designing and conducting clinical trials 
that suit the complexities of acupuncture treatments, especially when it comes to blinding and 
selection of control interventions. 
Comparative results presented here, particularly in regards to rescue medication and reduction 
in migraine days, all point towards the fact that acupuncture provides effective prophylaxis 
for migraines.  
Comparisons of prophylactic drugs versus acupuncture find fewer patients reporting adverse 
effects and a lower dropout rate in favour of all the acupuncture groups reviewed from the six 
trials. As public awareness increases in regards to the considerable side-effects of 
prophylactic drugs, acupuncture can only gain popularity over time. 
From the National Institute of Clinical Excellence (NICE) guidelines (2012) sections 1.3.16-
1.3.18 advise that after taking into consideration the persons preference, comorbidities, risk of 
adverse effects and the impact on their quality of life from migraines, that topiramate or 
propanolol can be taken. If neither are suitable of ineffective, a course of 10 sessions of 
acupuncture should be considered over a period of 5-8 weeks. 
This recommendation is a massive leap forward for the credibility of acupuncture treating 
migraines and for the awareness of acupuncture to the general public. Up to ten sessions are 
recommended. Therefore one can expect that acupuncture has a cumulative effect and it 
would take, by recommendation from NICE, a minimum of ten sessions to show its efficacy 
and effectiveness over treating migraines. 
Several problems arise from this recommendation: a) topiramate and propanolol are still 
offered as first line treatment and acupuncture as a second recommendation and b) the lack of 
acupuncture involvement in the infrastructure of the NHS leads to many members of the 
public unable to afford acupuncture treatment. 
In addition, many important issues remain unresolved. The real cost of implementing 
acupuncture clinics and employing acupuncturists within the infrastructure of the NHS should 
be evaluated. One successful example in South East London is the Gateway complementary 
therapy clinic within Lambeth Hospital, which has been running successfully for many years. 
This model could be replicated in other parts of the country within the infrastructure of the 
NHS. Optimal treatment length protocols need to be determined by improving study design, 
thereby allowing migraineurs minimum acupuncture sessions but still providing the maximum 
migraine-free period, therefore maximising the cost-effectiveness of acupuncture within the 
National Health System in the UK and potentially all public health systems around the world.  
The fact that Europe alone spends 27 billion Euros a year on migraine research (Lekander et 
al., 2007) and proven research that drugs perform significantly worse than acupuncture when 
adverse events and side-effects are taken into consideration, should place acupuncture in the 
forefront of migraine prophylaxis. 
5. CONCLUSION 
Evidence presented in this review suggests that acupuncture is an effective treatment for 
chronic migraineurs, particularly in patients who cannot tolerate the vast array of implicated 
side-effects associated with standardized drug therapy.  
NICE guidelines may need to be updated to incorporate acupuncture as a first line treatment 
on a par with the current pharmacological drugs such as topiramate and propanolol.  
Designs of future trials should aim to be more homogeneous so as to facilitate future 
comparative studies that can generate rigorous data to inform clinical practice. In addition, 
future study design should aim to optimize the full potential of acupuncture in the treatment 
of migraines; they should aim at more closely replicating the individualized treatment 
provided in routine care environment, which also incorporates additional TCM modalities.  
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